Ostro, recently rebranded from RxDefine, is getting an e-commerce makeover and $45 million in Series B funding, CEO Chase Feiger tells Axios exclusively.
Why it matters: Retail and finance companies are accustomed to having a wealth of user engagement and tracking tools at their fingertips, but that same innovation has been slow to come to health care.
